Follow-up on ECMO after Cardiac Surgery: How Can We Evaluate Therapy?
DOI:
https://doi.org/10.1532/hsf.2147Abstract
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) provides temporary cardiorespiratory support for patients in cardiogenic shock despite high-dose inotropic therapy and use of an intra-aortic balloon pump (IABP) [Muehrcke 1996]. Postcardiotomy cardiogenic shock has an incidence of 2%-6% after routine adult cardiac surgery [Hernandez 2007]. There are 0.5%-1.5% of patients who are refractory to medical and device therapy, and cardiogenic shock can lead to multiorgan dysfunction and mortality [Rastan 2010]. Prolonged cardiorespiratory support, which can be achieved with ECMO, may provide time for myocardial recovery and prevent multiorgan dysfunction and reduce mortality [Smedira 2001]. However, this device is associated with serious complications [Khorsandi 2017]. The reported survival rate on ECMO is 36% [Biancari 2018].
The aim of this study is to follow up on factors that can influence therapy outcome for patients who receive VA-ECMO after cardiac surgery.
References
Biancari F, Perrotti A, Dalen M, et al. 2018. Meta-analysis of the outcome after postcardiotomy venoarterial extracorporeal membrane oxygenation in adult patients. J Cardiothorac Vasc Anesth 32:1175-82.
Charlesworth M, Venkateswaran R, Barker JM, Feddy L. 2017. Postcardiotomy VA-ECMO for refractory cardiogenic shock. J Cardiothorac Surg 12:116.
Elsharkawy HA, Li L, Esa WA, Sessler DI, Bashour CA. 2010. Outcome in patients who require venoarterial extracorporeal membrane oxygenation support after cardiac surgery. J Cardiothorac Vasc Anesth 24:946-51.
Guihaire J, Dang Van S, Rouze S, et al. 2017. Clinical outcomes in patients after extracorporeal membrane oxygenation support for post-cardiotomy cardiogenic shock: a single-centre experience of 92 cases. Interact Cardiovasc Thorac Surg 25:363-9.
Hernandez AF, Grab JD, Gammie JS, et al. 2007. A decade of short-term outcomes in post cardiac surgery ventricular assist device implantation: data from the Society of Thoracic Surgeons’ National Cardiac Database. Circulation 116:606-12.
Khorsandi M, Dougherty S, Bouamra O, et al. 2017. Extra-corporeal membrane oxygenation for refractory cardiogenic shock after adult cardiac surgery: a systematic review and meta-analysis. J Cardiothorac Surg 12:55.
Muehrcke DD, McCarthy PM, Stewart RW, et al. 1996. Extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock. Ann Thorac Surg 61:684-91.
Nwozuzu A, Fontes ML, Schonberger RB. 2016. Mobile extracorporeal membrane oxygenation teams: the North American versus the European experience. J Cardiothorac Vasc Anesth 30:1441-8.
Pappalardo F, Montisci A. 2016. Veno-arterial extracorporeal membrane oxygenation (VA ECMO) in postcardiotomy cardiogenic shock: how much pump flow is enough? J Thorac Dis 8:E1444-8.
Rastan AJ, Dege A, Mohr M, et al. 2010. Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg 139:302-11, 311.e1.
Smedira NG, Blackstone EH. 2001. Postcardiotomy mechanical support: risk factors and outcomes. Ann Thorac Surg. 71(3 suppl):S60-6; discussion S82-5.
Wang L, Wang H, Hou X. 2018. Clinical outcomes of adult patients who receive extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth 32:2087-93.
